Ontology highlight
ABSTRACT: Background
Morbidly obese (MO) patients are increasingly undergoing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) for severe aortic stenosis (AS). However, the best therapeutic strategy for these patients remains a matter for debate.Aims
Our aim was to compare the periprocedural and mid-term outcomes in MO patients undergoing TAVR versus SAVR.Methods
A multicentre retrospective study including consecutive MO patients (body mass index ≥40 kg/m2, or ≥35 kg/m2 with obesity-related comorbidities) from 18 centres undergoing either TAVR (n=860) or biological SAVR (n=696) for severe AS was performed. Propensity score matching resulted in 362 pairs.Results
After matching, periprocedural complications
SUBMITTER: McInerney A
PROVIDER: S-EPMC10241265 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature